BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 25169546)

  • 1. Utility of nuclear morphometry in effusion cytology.
    Ambroise MM; Jothilingam P; Ramdas A
    Asian Pac J Cancer Prev; 2014; 15(16):6919-22. PubMed ID: 25169546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manual and automated AgNOR count in differentiating reactive mesothelial from metastatic malignant cells in serous effusions.
    Mohanty SK; Dey P; Rana P
    Anal Quant Cytol Histol; 2003 Oct; 25(5):273-6. PubMed ID: 14603724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of DNA flow cytometry and image cytometry on effusion fluid.
    Saha I; Dey P; Vhora H; Nijhawan R
    Diagn Cytopathol; 2000 Feb; 22(2):81-5. PubMed ID: 10649516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphological markers of chromosomal instability as predictors of malignancy in pleural effusion.
    Aggarwal P; Handa U; Bhagat R; Aggarwal D
    Diagn Cytopathol; 2024 Feb; 52(2):76-81. PubMed ID: 37946685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Image cytometry: an aid for cytological diagnosis of pleural effusions.
    Osterheld MC; Liette C; Anca M
    Diagn Cytopathol; 2005 Mar; 32(3):173-6. PubMed ID: 15690335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnostic utility of D2-40, calretinin, CK5/6, desmin and MOC-31 in the differentiation of mesothelioma from adenocarcinoma in pleural effusion cytology.
    Hyun TS; Barnes M; Tabatabai ZL
    Acta Cytol; 2012; 56(5):527-32. PubMed ID: 23075894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complementary value of DNA flow cytometry and image morphometry in detection of malignant cells in effusion fluids.
    Bisht B; Handa U; Mohan H; Lehl SS
    Malays J Pathol; 2014 Aug; 36(2):83-90. PubMed ID: 25194530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The application of immunocytochemistry to direct smears in the diagnosis of effusions.
    Knoepp SM; Placido J; Fields KL; Thomas D; Roh MH
    Diagn Cytopathol; 2013 May; 41(5):425-30. PubMed ID: 22549950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Nuclear Morphometry in the Cytologic Evaluation of Benign and Malignant Thyroid Lesions.
    Bhuiyan AZ; Habib S; Hossain SA; Rahman MH; Ahasan MA; Amanullah M
    Mymensingh Med J; 2023 Oct; 32(4):939-946. PubMed ID: 37777884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [THE MORPHOMETRY IN CYTOLOGICAL ANALYSIS OF EXUDATIVE FLUIDS].
    Snikhovskaya KV; Shabalova IP
    Klin Lab Diagn; 2015 Aug; 60(8):32-6. PubMed ID: 26596045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of malignant mesothelioma using nuclear structure of mesothelial cells in effusion cytology specimens.
    Tosun AB; Yergiyev O; Kolouri S; Silverman JF; Rohde GK
    Cytometry A; 2015 Apr; 87(4):326-33. PubMed ID: 25598227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of nucleolar organiser regions and DNA flow cytometry in the evaluation of pleural effusion.
    Huang MS; Tsai MS; Hwang JJ; Wang TH
    Thorax; 1994 Nov; 49(11):1152-6. PubMed ID: 7831633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions.
    Friedman MT; Gentile P; Tarectecan A; Fuchs A
    Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Routine DNA cytometry of benign and malignant pleural effusions by means of the remote quantitation server Euroquant: a prospective study.
    Kayser K; Blum S; Beyer M; Haroske G; Kunze KD; Meyer W
    J Clin Pathol; 2000 Oct; 53(10):760-4. PubMed ID: 11064669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serous effusions in malignant lymphomas: a review.
    Das DK
    Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different expression of FoxM1 in human benign and malignant pleural effusion.
    Tang Z; Li H; Zhu H; Bai C
    Med Oncol; 2015 Jan; 32(1):312. PubMed ID: 25491139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lamellar Inclusions within Hyperplastic Endoplasmic Reticulum in Benign Mesothelial Cells.
    Haefliger S; Jain D; Menter T; Vlajnic T; Savic Prince S; Hopfer H; Mihatsch MJ; Bubendorf L
    Acta Cytol; 2020; 64(6):572-576. PubMed ID: 32599592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of Nuclear Morphometry in Breast Lesions: A Cross-Sectional Study.
    Girdhar A; Raju K; P N S
    Cureus; 2023 May; 15(5):e39378. PubMed ID: 37378137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of AgNOR count in differentiating malignant cells from reactive mesothelial cells in serous effusions.
    Sujathan K; Kannan S; Pillai KR; Chandralekha B; Amma NS; Nair MK
    Acta Cytol; 1996; 40(4):724-8. PubMed ID: 8693893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions.
    Illei PB; Ladanyi M; Rusch VW; Zakowski MF
    Cancer; 2003 Feb; 99(1):51-6. PubMed ID: 12589646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.